Nanosonics Limited
NNCSF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$848.91M
Close$
$1.13
38.4% downside
Current Fair Value
38.4% downsideOvervalued by 38.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $848.91 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0.06 |
| Beta | 1.2 |
| Outstanding Shares | 300,851,252 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 48.22 |
|---|---|
| PEG | -193.22 |
| Price to Sales | 1.84 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
August 24, 2026
EPS Estimate
$0.02
Consensus analyst estimateRevenue Estimate
$75.77 M
Consensus analyst estimateNext Earnings Call
Expected Date
February 23, 2027
EPS Estimate
$0.01
Consensus analyst estimateRevenue Estimate
$74.66 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Nanosonics Limited
508 employees
CEO: Michael C. Kavanagh
Nanosonics Limited, along with its subsidiaries, functions as a global infection prevention enterprise with operations in Australia and beyond. The company focuses on the production and distribution of its trophon ultrasound probe disinf...